Results 211 to 220 of about 495,544 (318)

Large-scale prokaryotic gene prediction and comparison to genome annotation [PDF]

, 2005
Pernille Nielsen, Anders Krogh
openalex   +1 more source

CSF Mitochondrial DNA: Biomarker of Body Composition and Energy Metabolism in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cerebrospinal fluid (CSF) cell‐free mitochondrial DNA (cf‐mtDNA) is a potential biomarker for Parkinson's disease (PD), but its clinical relevance remains unclear. We investigated associations between CSF cf‐mtDNA levels, body composition, nutritional status, and metabolic biomarkers in PD. Methods CSF cf‐mtDNA levels, defined as the
Yasuaki Mizutani, Tsuyoshi Nakai, Yasuhiro Maeda, Reiko Ohdake, Atsuhiro Higashi, Toshiki Maeda, Ryunosuke Nagao, Sayuri Shima, Kazuya Kawabata, Akihiro Ueda, Mizuki Ito, Hirohisa Watanabe   +11 more
wiley   +1 more source

Genomic language models with k-mer tokenization strategies for plant genome annotation and regulatory element strength prediction. [PDF]

Plant Mol Biol
Suzuki S, Horie K, Amagasa T, Fukuda N.
europepmc   +1 more source

PhaGAA: an integrated web server platform for phage genome annotation and analysis. [PDF]

Bioinformatics, 2023
Wu J, Liu Q, Li M, Xu J, Wang C, Zhang J, Xiao M, Bin Y, Xia J.   +8 more
europepmc   +1 more source

A computational and experimental approach to validating annotations and gene predictions in the Drosophila melanogaster genome [PDF]

, 2005
Mark Yandell, Adina Bailey, Sima Misra, Shengqiang Shu, C. van der Wiel, Martha Evans-Holm, S Celniker, Gerald M. Rubin   +7 more
openalex   +1 more source

Moyamoya Disease and the Risk of Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by the progressive narrowing of arteries at the base of the brain, forming abnormal collateral vascular networks. While vascular parkinsonism is noted in MMD, its link to Parkinson's disease (PD) has not been explored.
Dallah Yoo, Jeong‐Yong Shin, Rugyeom Lee, Jiwon Cheon, Ji Hun Kim, Doeun Kim, Jae‐Kyung Won, In‐Hwan Oh, Yunjong Lee, Tae‐Beom Ahn   +9 more
wiley   +1 more source

High-Performance Genome Annotation for a Safer and Faster-Developing Phage Therapy. [PDF]

Viruses
Culot A, Abriat G, Furlong KP.
europepmc   +1 more source

The Mouse Functional Genome Database (MfunGD): functional annotation of proteins in the light of their cellular context [PDF]

, 2005
Andreas Ruepp
openalex   +1 more source

INF2‐Related Charcot–Marie–Tooth Disease in a Japanese Cohort: Genetic and Clinical Insights

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background INF2 mutations cause focal segmental glomerulosclerosis (FSGS) and Charcot–Marie–Tooth disease (CMT). Accurate genetic diagnosis is critical, as INF2‐related FSGS is typically resistant to immunotherapy yet rarely recurs after transplantation, and its associated neuropathy can mimic treatable immune‐mediated disorders such as ...
Chikashi Yano, Masahiro Ando, Yujiro Higuchi, Jun‐Hui Yuan, Akiko Yoshimura, Takahiro Hobara, Risa Nagatomo, Fumikazu Kojima, Yu Hiramatsu, Satoshi Nozuma, Tomonori Nakamura, Yusuke Sakiyama, Chika Matsuoka, Toru Yamashita, Takashi Kimura, Ayako Miyazaki, Chinatsu Kinjo, Kenji Yokochi, Nanami Yamanaka, Nozomu Matsuda, Tomoki Suichi, Yoshiyuki Hanaoka, Haruka Kojima, Kenichi Todo, Hiroyuki Ishiura, Jun Mitsui, Shoji Tsuji, Hiroshi Takashima   +27 more
wiley   +1 more source

Evaluation of strategies for evidence-driven genome annotation using long-read RNA-seq. [PDF]

Genome Res
Paniagua A, Agustín-García C, Pardo-Palacios FJ, Brown T, De Maria M, Denslow ND, Mazzoni CJ, Conesa A.   +7 more
europepmc   +1 more source